<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00952211</url>
  </required_header>
  <id_info>
    <org_study_id>HL091848</org_study_id>
    <nct_id>NCT00952211</nct_id>
  </id_info>
  <brief_title>Burden of Obstructive Sleep Apnea in Stroke (BOSAST)</brief_title>
  <acronym>BOSAST</acronym>
  <official_title>Burden of Obstructive Sleep Apnea in Stroke (BOSAST)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Diego</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, San Diego</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      There are two purposes of this study. The first purpose is to define the frequency of
      obstructive sleep apnea in stroke survivors as well as its association with fatigue and
      quality of life. The second purpose is to determine if continuous positive airways pressure
      (CPAP) treatment can have a beneficial effect on these patients' fatigue and quality of life.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Stroke survivors frequently complain of fatigue, depressive symptoms, and decreased cognitive
      functioning. These burdens complicate the recovery and rehabilitation from stroke. While
      there may be many contributing factors to these burdens, one factor in particular may be both
      terribly common and yet readily susceptible to intervention. Consistent reports from around
      the world demonstrate that &gt;50% of stroke patients have obstructive sleep apnea (OSA), a
      disorder that is also associated with fatigue, depressive symptoms, and decreased cognitive
      functioning. OSA is also associated with increases in inflammatory products which themselves
      are associated with the same array of burdens.

      This study will examine inpatients at a stroke rehabilitation center. Patients' sleep will be
      studied. Patients with OSA will be randomized to 10 days treatment double blind with either
      continuous positive airways pressure (CPAP) treatment or to sub-therapeutic CPAP treatment.
      After 10 days of treatment, the OSA patients and the stroke patient without OSA will be
      restudied.

      The study will shed light on the impact of OSA on stroke patients' burdens.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    problems with recruitment
  </why_stopped>
  <start_date>August 2009</start_date>
  <completion_date type="Actual">June 2011</completion_date>
  <primary_completion_date type="Actual">June 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Profile of Mood States (POMS) - Fatigue Subscale</measure>
    <time_frame>10 days after beginning CPAP treatment</time_frame>
    <description>POMS fatigue subscale: 7 items; range 0-28; higher score indicates worse symptoms, i.e., more fatigue</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hospital Anxiety and Depression (HADS) Scale -Depression Subscale</measure>
    <time_frame>10 days after beginning CPAP treatment</time_frame>
    <description>HADS depression subscale: 7 items, range 0-21. Higher score indicates worse symptoms</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">3</enrollment>
  <condition>Stroke</condition>
  <condition>Obstructive Sleep Apnea</condition>
  <arm_group>
    <arm_group_label>CPAP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>CPAP at therapeutic pressure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sub-therapeutic CPAP</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>CPAP administered at sub-therapeutic pressure</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CPAP</intervention_name>
    <description>CPAP at therapeutic pressure during nighttime</description>
    <arm_group_label>CPAP</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CPAP at sub-therapeutic pressure</intervention_name>
    <description>CPAP delivered at sub-therapeutic pressure at nighttime</description>
    <arm_group_label>sub-therapeutic CPAP</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  stroke survivor in stroke rehabilitation unit

          -  age 45-85

          -  able to consent

          -  no prior treatment with CPAP

        Exclusion Criteria:

          -  complex apnea

          -  known inflammatory disease

          -  neurological disease precluding patient's ability to consent and cooperate
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joel Dimsdale, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UCSD</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UCSD</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 3, 2009</study_first_submitted>
  <study_first_submitted_qc>August 3, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 6, 2009</study_first_posted>
  <results_first_submitted>January 27, 2016</results_first_submitted>
  <results_first_submitted_qc>March 7, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">April 4, 2016</results_first_posted>
  <last_update_submitted>March 7, 2016</last_update_submitted>
  <last_update_submitted_qc>March 7, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 4, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, San Diego</investigator_affiliation>
    <investigator_full_name>Joel E. Dimsdale, M.D.</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>stroke</keyword>
  <keyword>obstructive sleep apnea</keyword>
  <keyword>fatigue</keyword>
  <keyword>quality of life</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>The study opened for enrollment on 9/16/09 at San Diego Rehabilitation Institute. Enrollment was halted in April 2011 and the study terminated due to low recruitment numbers.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>CPAP</title>
          <description>CPAP at therapeutic pressure
CPAP: CPAP at therapeutic pressure during nighttime</description>
        </group>
        <group group_id="P2">
          <title>Sub-therapeutic CPAP</title>
          <description>CPAP administered at sub-therapeutic pressure
CPAP at sub-therapeutic pressure: CPAP delivered at sub-therapeutic pressure at nighttime</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>CPAP</title>
          <description>CPAP at therapeutic pressure
CPAP: CPAP at therapeutic pressure during nighttime</description>
        </group>
        <group group_id="B2">
          <title>Sub-therapeutic CPAP</title>
          <description>CPAP administered at sub-therapeutic pressure
CPAP at sub-therapeutic pressure: CPAP delivered at sub-therapeutic pressure at nighttime</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="3"/>
            <count group_id="B2" value="0"/>
            <count group_id="B3" value="3"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Profile of Mood States (POMS) - Fatigue Subscale</title>
        <description>POMS fatigue subscale: 7 items; range 0-28; higher score indicates worse symptoms, i.e., more fatigue</description>
        <time_frame>10 days after beginning CPAP treatment</time_frame>
        <population>Data only available for 2 subjects; one subject did not provide data for this questionnaire.</population>
        <group_list>
          <group group_id="O1">
            <title>CPAP</title>
            <description>CPAP at therapeutic pressure
CPAP: CPAP at therapeutic pressure during nighttime</description>
          </group>
          <group group_id="O2">
            <title>Sub-therapeutic CPAP</title>
            <description>CPAP administered at sub-therapeutic pressure
CPAP at sub-therapeutic pressure: CPAP delivered at sub-therapeutic pressure at nighttime</description>
          </group>
        </group_list>
        <measure>
          <title>Profile of Mood States (POMS) - Fatigue Subscale</title>
          <description>POMS fatigue subscale: 7 items; range 0-28; higher score indicates worse symptoms, i.e., more fatigue</description>
          <population>Data only available for 2 subjects; one subject did not provide data for this questionnaire.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10" spread="2.83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hospital Anxiety and Depression (HADS) Scale -Depression Subscale</title>
        <description>HADS depression subscale: 7 items, range 0-21. Higher score indicates worse symptoms</description>
        <time_frame>10 days after beginning CPAP treatment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>CPAP</title>
            <description>CPAP at therapeutic pressure
CPAP: CPAP at therapeutic pressure during nighttime</description>
          </group>
          <group group_id="O2">
            <title>Sub-therapeutic CPAP</title>
            <description>CPAP administered at sub-therapeutic pressure
CPAP at sub-therapeutic pressure: CPAP delivered at sub-therapeutic pressure at nighttime</description>
          </group>
        </group_list>
        <measure>
          <title>Hospital Anxiety and Depression (HADS) Scale -Depression Subscale</title>
          <description>HADS depression subscale: 7 items, range 0-21. Higher score indicates worse symptoms</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8" spread="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>CPAP</title>
          <description>CPAP at therapeutic pressure
CPAP: CPAP at therapeutic pressure during nighttime</description>
        </group>
        <group group_id="E2">
          <title>Sub-therapeutic CPAP</title>
          <description>CPAP administered at sub-therapeutic pressure
CPAP at sub-therapeutic pressure: CPAP delivered at sub-therapeutic pressure at nighttime</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Joel Dimsdale</name_or_title>
      <organization>UCSD</organization>
      <email>jdimsdale@ucsd.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

